Efficacy of pneumococcal polysaccharide vaccine

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 11, 2009, Pages 1134-1135

  Scott, Pippa ^a   Huss, Anke ^a   Stuck, Andreas E ^b   Trotter, Caroline ^c   Egger, Matthias ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE;

DRUG EFFICACY; HEALTH CARE ORGANIZATION; HUMAN; LETTER; PNEUMONIA; RISK FACTOR; VACCINATION; METHODOLOGY; NOTE; PNEUMOCOCCAL INFECTION; TREATMENT OUTCOME;

HUMANS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; TREATMENT OUTCOME; VACCINATION;

EID: 67049137443     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1090018     Document Type: Letter

References (6)

1. Huss A, Scott P, Stuck AE, et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009;180:48-58.
2. Andrews R, Moberley SA. The controversy over the efficacy of pneumococcal vaccine. CMAJ 2009;180:18-19
3. Moberley SA, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008;(1):CD000422. (Pubitemid 351807720)
4. Guyatt GH, Oxman AD, Vist GE, et al.; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-926 (Pubitemid 351632017)
5. World Health Organization. 23-Valent pneumococcal polysaccharide vaccine: WHO position paper. Wkly Epidemiol Rec 2008;83:373-384 Available: www.who.int/wer/2008/wer8342.pdf (accessed 2009 Apr. 29).
6. World Health Organization. Pneumococcal vaccines: WHO position paper. Wkly Epidemiol Rec 2003;78:110-119 Available: www.who.int/wer/2003/en/wer7814. pdf (accessed 2009 Apr. 29).